BELITE BIO INC

Belite Bio, a Nasdaq‑listed San Diego biopharma, targets age‑related metabolic diseases like macular degeneration, liver disease, and diabetes with cutting‑edge therapeutics, promising long‑term returns amid volatile stock swings.

Belite Bio, Inc. is a clinical-stage biopharmaceutical company pioneering novel therapeutics for age-related metabolic diseases such as macular degeneration, liver disease, and diabetes.